Ariadna Padró‐Miquel

Implication between Genetic Variants from APOA5 and ZPR1 and NAFLD Severity in Patients with Hypertriglyceridemia

Virginia Esteve‐Luque, Ariadna Padró‐Miquel, Marta Fanlo‐Maresma et al. · Nutrients · 2021 · 50 citations · Full text

A prospective controlled, randomized clinical trial of kidney transplant recipients developed personalized tacrolimus dosing using model-based Bayesian Prediction

Núria Lloberas, Josep M. Grinyó, Helena Colom et al. · Kidney International · 2023 · 36 citations · Full text

Model-based Bayesian Prediction, Kidney Transplant, Medicine +8

KIF6 gene as a pharmacogenetic marker for lipid-lowering effect in statin treatment

Cristina Ruiz-Iruela, Ariadna Padró‐Miquel, Xavier Pintó et al. · PLoS ONE · 2018 · 24 citations · Full text

Association of ANRIL gene polymorphisms with major adverse cardiovascular events in hemodialysis patients

Ariadna Arbiol‐Roca, Ariadna Padró‐Miquel, Miguel Hueso et al. · Clinica Chimica Acta · 2017 · 23 citations

Anril Gene Polymorphisms, Hemodialysis, Hypertension +13

Influence of 6 genetic variants on the efficacy of statins in patients with dyslipidemia

Ruth Cano‐Corres, Beatriz Candás‐Estébanez, Ariadna Padró‐Miquel et al. · Journal of Clinical Laboratory Analysis · 2018 · 18 citations · Full text